Advertisement
U.S. markets open in 5 hours 37 minutes
  • S&P Futures

    5,208.25
    -6.50 (-0.12%)
     
  • Dow Futures

    39,218.00
    -5.00 (-0.01%)
     
  • Nasdaq Futures

    18,182.75
    -48.75 (-0.27%)
     
  • Russell 2000 Futures

    2,046.80
    -3.00 (-0.15%)
     
  • Crude Oil

    82.70
    -0.02 (-0.02%)
     
  • Gold

    2,158.40
    -5.90 (-0.27%)
     
  • Silver

    25.15
    -0.11 (-0.46%)
     
  • EUR/USD

    1.0859
    -0.0018 (-0.16%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.48
    +0.15 (+1.05%)
     
  • dólar/libra

    1.2697
    -0.0032 (-0.25%)
     
  • USD/JPY

    150.2800
    +1.1820 (+0.79%)
     
  • Bitcoin USD

    64,509.54
    -3,698.41 (-5.42%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,722.55
    -4.87 (-0.06%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

Natus Medical: 2Q Earnings Snapshot

Natus Medical: 2Q Earnings Snapshot

PLEASANTON, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported a loss of $2.6 million in its second quarter.

On a per-share basis, the Pleasanton, California-based company said it had a loss of 8 cents. Earnings, adjusted for non-recurring costs, were 35 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 26 cents per share.

The maker of medical device for newborn care posted revenue of $130.7 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $130.6 million.

For the current quarter ending in October, Natus Medical expects its per-share earnings to range from 40 cents to 44 cents.

The company expects full-year earnings in the range of $1.50 to $1.60 per share.

Natus Medical shares have decreased 17 percent since the beginning of the year. The stock has declined 17 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BABY at https://www.zacks.com/ap/BABY

Advertisement